MyFinsight
Home
Blog
About
Contact
Net income (loss)
$137,162K
Accounts payable and
accrued expenses
$45,937K
Change in fair value of
partner company...
-$7,085K
Income taxes payable
$5,062K
Accounts receivable
-$4,761K
Stock-based compensation
expense
$1,756K
Amortization of debt discount
$1,455K
Amortization of acquired
intangible assets
$1,126K
Other long-term
liabilities
$887K
Reduction in the carrying
amount of operating...
$480K
Inventory
-$332K
Depreciation expense
$93K
Prepaid expenses and
other current assets
-$56K
Bad debt expense
$30K
Net cash provided by
(used in) operating...
$203,851K
Canceled cashflow
$2,371K
Net increase in cash
and cash...
$176,460K
Canceled cashflow
$27,391K
Change in fair value of
investment
$1,047K
Lease liabilities
-$550K
Other receivables -
related party
$358K
Other assets
$339K
Settlement of partner
company payables
-$76K
Change in fair value of
partner companies'...
-$1K
Exercise of warrants for
cash
$1,218K
Proceeds from partner
companies' espp
$148K
Proceeds from exercise of
partner company's...
$72K
Net cash provided by
(used in) financing...
-$27,391K
Canceled cashflow
$1,438K
Repayment of oaktree note
and debt issuance...
$14,494K
Redemption of partner
company preferred...
$14,170K
Exchange of partner
company preferred...
$165K
Back
Back
Cash Flow
Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. (FBIO)
source: myfinsight.com